The purpose of this study was to identify potential gender discrepancies in adaptation to low-volume high-intensity interval training (HIT). Active, young men (n = 11, age = 25.3 ± 5.5 years) and women (n = 9, age = 25.2 ± 3.1 years) matched for age, physical activity, and VO(2max) completed six sessions of HIT separated by 48 h over a 2-3 week period. Subjects completed four Wingate tests on days 1 and 2, five on days 3 and 4, and six on days 5 and 6. A control group of five men and four women (age = 22.8 ± 2.8 years) completed all testing, but did not perform HIT. Changes in VO(2max), oxygen (O(2)) pulse, peak/mean power output, fatiguability, substrate oxidation, and voluntary force production of the knee flexors and extensors were examined pre- and post-training with repeated measures ANOVA, with gender and group as between-subjects variables. Results showed significant (p < 0.05) improvements in VCO(2max) and peak/mean power output in response to HIT, as well as reduced respiratory exchange ratio and heart rate during submaximal exercise. The magnitude of change in VO(2max) (5.9 vs. 6.8%), power output (10.4-14.9% vs. 9.1-10.9%), and substrate oxidation was similar (p > 0.05) between men and women. Data show that adaptations to 6 days of low-volume HIT are similar in men and women matched for VO(2max) and physical activity.

Background: Due to COVID-19, many centres adopted a change to the diagnosis of GDM. Methods: A case-control study of antenatal patients between 1 April and 30 June in 2019 and 2020 looking at detection rates of GDM, use of medication, obstetric, and fetal outcomes. Results: During COVID-19, the rate of positive GDM tests approximately halved (20% (42/210) in 2020 vs. 42.2% (92/218) in 2019, (p < 0.01)) with higher rates of requirement for insulin at diagnosis (21.4% (2020) vs. 2.2% (2019); p < 0.01), and at term (31% (2020) vs. 5.4% (2019); p < 0.01). and metformin at diagnosis (4.8% (2020) vs. 1.1% (2019); p < 0.01), and at term (14.3% (2020) vs. 7.6% (2019) p < 0.01), with no differences in birth outcomes. Conclusions: There was likely an underdiagnosis of GDM while women at a higher risk of hyperglycaemia were correctly identified. The GTT should be maintained as the gold-standard test where possible, with provisions made for social distancing during testing if required.

No abstract

No abstract

Eighteen children with hemiplegia, mean age 8 years 5 months, underwent gait analysis and musculoskeletal modelling using specially designed software. The maximum lengths of the hamstrings were determined for each child walking in and out of an ankle‐foot orthosis (AFO). The muscles were deemed to be short if shorter than the normal average ‐1SD. In bare feet 8 participants had short medial hamstrings with a higher proportion of these in the less involved individuals. All participants showed an increase in maximum hamstring length when wearing an AFO. In all but one child this was sufficient to restore hamstring length to within normal limits. These finding suggest that hamstring pathology in hemiplegic gait is usually secondary to more distal lower limb pathology.